Cohen B A
Department of Neurology, Northwestern University Medical School, 710 North Lake Shore Drive, Abbott Hall 1121, Chicago, IL 60611, USA.
Curr Neurol Neurosci Rep. 2001 Nov;1(6):518-25. doi: 10.1007/s11910-001-0056-0.
Advances in molecular biology and immunology provide new, highly sensitive and specific techniques that can be applied to analysis of cerebrospinal fluid to enhance the diagnosis and treatment of central nervous system (CNS) infections. In addition to improved accuracy and speed of diagnosis, these modalities may offer improved means of monitoring treatment efficacy, establishing prognosis, detecting organism resistance, and tracking epidemic sources. This brief review discusses a number of recent papers applying these methods, in order to illustrate their value and significance for clinical neurologic practice. Some of these applications are commonly available, whereas others are likely to enter the physician's armamentarium in the near future. As they do, they can be expected to improve the treatment of CNS infections.
分子生物学和免疫学的进展提供了新的、高度敏感且特异的技术,这些技术可应用于脑脊液分析,以加强中枢神经系统(CNS)感染的诊断和治疗。除了提高诊断的准确性和速度外,这些方法还可能提供更好的监测治疗效果、确定预后、检测病原体耐药性以及追踪传染源的手段。本简要综述讨论了一些应用这些方法的近期论文,以阐明它们在临床神经学实践中的价值和意义。其中一些应用已普遍可用,而其他一些可能在不久的将来进入医生的诊疗手段。随着它们的应用,有望改善CNS感染的治疗。